Cargando…

Feasibility of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: First Evidence from Studies in Mali and Senegal

BACKGROUND: Mass treatment with ivermectin is a proven strategy for controlling onchocerciasis as a public health problem, but it is not known if it can also interrupt transmission and eliminate the parasite in endemic foci in Africa where vectors are highly efficient. A longitudinal study was under...

Descripción completa

Detalles Bibliográficos
Autores principales: Diawara, Lamine, Traoré, Mamadou O., Badji, Alioune, Bissan, Yiriba, Doumbia, Konimba, Goita, Soula F., Konaté, Lassana, Mounkoro, Kalifa, Sarr, Moussa D., Seck, Amadou F., Toé, Laurent, Tourée, Seyni, Remme, Jan H. F.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710500/
https://www.ncbi.nlm.nih.gov/pubmed/19621091
http://dx.doi.org/10.1371/journal.pntd.0000497
_version_ 1782169382049284096
author Diawara, Lamine
Traoré, Mamadou O.
Badji, Alioune
Bissan, Yiriba
Doumbia, Konimba
Goita, Soula F.
Konaté, Lassana
Mounkoro, Kalifa
Sarr, Moussa D.
Seck, Amadou F.
Toé, Laurent
Tourée, Seyni
Remme, Jan H. F.
author_facet Diawara, Lamine
Traoré, Mamadou O.
Badji, Alioune
Bissan, Yiriba
Doumbia, Konimba
Goita, Soula F.
Konaté, Lassana
Mounkoro, Kalifa
Sarr, Moussa D.
Seck, Amadou F.
Toé, Laurent
Tourée, Seyni
Remme, Jan H. F.
author_sort Diawara, Lamine
collection PubMed
description BACKGROUND: Mass treatment with ivermectin is a proven strategy for controlling onchocerciasis as a public health problem, but it is not known if it can also interrupt transmission and eliminate the parasite in endemic foci in Africa where vectors are highly efficient. A longitudinal study was undertaken in three hyperendemic foci in Mali and Senegal with 15 to 17 years of annual or six-monthly ivermectin treatment in order to assess residual levels of infection and transmission and test whether ivermectin treatment could be safely stopped in the study areas. METHODOLOGY/PRINCIPAL FINDINGS: Skin snip surveys were undertaken in 126 villages, and 17,801 people were examined. The prevalence of microfilaridermia was <1% in all three foci. A total of 157,500 blackflies were collected and analyzed for the presence of Onchocerca volvulus larvae using a specific DNA probe, and vector infectivity rates were all below 0.5 infective flies per 1,000 flies. Except for a subsection of one focus, all infection and transmission indicators were below postulated thresholds for elimination. Treatment was therefore stopped in test areas of 5 to 8 villages in each focus. Evaluations 16 to 22 months after the last treatment in the test areas involved examination of 2,283 people using the skin snip method and a DEC patch test, and analysis of 123,000 black flies. No infected persons and no infected blackflies were detected in the test areas, and vector infectivity rates in other catching points were <0.2 infective flies per 1,000. CONCLUSION/SIGNIFICANCE: This study has provided the first empirical evidence that elimination of onchocerciasis with ivermectin treatment is feasible in some endemic foci in Africa. Although further studies are needed to determine to what extent these findings can be extrapolated to other endemic areas in Africa, the principle of elimination has been established. The African Programme for Onchocerciasis Control has adopted an additional objective to assess progress towards elimination endpoints in all onchocerciasis control projects and to guide countries on cessation of treatment where feasible.
format Text
id pubmed-2710500
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-27105002009-07-21 Feasibility of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: First Evidence from Studies in Mali and Senegal Diawara, Lamine Traoré, Mamadou O. Badji, Alioune Bissan, Yiriba Doumbia, Konimba Goita, Soula F. Konaté, Lassana Mounkoro, Kalifa Sarr, Moussa D. Seck, Amadou F. Toé, Laurent Tourée, Seyni Remme, Jan H. F. PLoS Negl Trop Dis Research Article BACKGROUND: Mass treatment with ivermectin is a proven strategy for controlling onchocerciasis as a public health problem, but it is not known if it can also interrupt transmission and eliminate the parasite in endemic foci in Africa where vectors are highly efficient. A longitudinal study was undertaken in three hyperendemic foci in Mali and Senegal with 15 to 17 years of annual or six-monthly ivermectin treatment in order to assess residual levels of infection and transmission and test whether ivermectin treatment could be safely stopped in the study areas. METHODOLOGY/PRINCIPAL FINDINGS: Skin snip surveys were undertaken in 126 villages, and 17,801 people were examined. The prevalence of microfilaridermia was <1% in all three foci. A total of 157,500 blackflies were collected and analyzed for the presence of Onchocerca volvulus larvae using a specific DNA probe, and vector infectivity rates were all below 0.5 infective flies per 1,000 flies. Except for a subsection of one focus, all infection and transmission indicators were below postulated thresholds for elimination. Treatment was therefore stopped in test areas of 5 to 8 villages in each focus. Evaluations 16 to 22 months after the last treatment in the test areas involved examination of 2,283 people using the skin snip method and a DEC patch test, and analysis of 123,000 black flies. No infected persons and no infected blackflies were detected in the test areas, and vector infectivity rates in other catching points were <0.2 infective flies per 1,000. CONCLUSION/SIGNIFICANCE: This study has provided the first empirical evidence that elimination of onchocerciasis with ivermectin treatment is feasible in some endemic foci in Africa. Although further studies are needed to determine to what extent these findings can be extrapolated to other endemic areas in Africa, the principle of elimination has been established. The African Programme for Onchocerciasis Control has adopted an additional objective to assess progress towards elimination endpoints in all onchocerciasis control projects and to guide countries on cessation of treatment where feasible. Public Library of Science 2009-07-21 /pmc/articles/PMC2710500/ /pubmed/19621091 http://dx.doi.org/10.1371/journal.pntd.0000497 Text en Diawara et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Diawara, Lamine
Traoré, Mamadou O.
Badji, Alioune
Bissan, Yiriba
Doumbia, Konimba
Goita, Soula F.
Konaté, Lassana
Mounkoro, Kalifa
Sarr, Moussa D.
Seck, Amadou F.
Toé, Laurent
Tourée, Seyni
Remme, Jan H. F.
Feasibility of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: First Evidence from Studies in Mali and Senegal
title Feasibility of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: First Evidence from Studies in Mali and Senegal
title_full Feasibility of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: First Evidence from Studies in Mali and Senegal
title_fullStr Feasibility of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: First Evidence from Studies in Mali and Senegal
title_full_unstemmed Feasibility of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: First Evidence from Studies in Mali and Senegal
title_short Feasibility of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: First Evidence from Studies in Mali and Senegal
title_sort feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in africa: first evidence from studies in mali and senegal
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2710500/
https://www.ncbi.nlm.nih.gov/pubmed/19621091
http://dx.doi.org/10.1371/journal.pntd.0000497
work_keys_str_mv AT diawaralamine feasibilityofonchocerciasiseliminationwithivermectintreatmentinendemicfociinafricafirstevidencefromstudiesinmaliandsenegal
AT traoremamadouo feasibilityofonchocerciasiseliminationwithivermectintreatmentinendemicfociinafricafirstevidencefromstudiesinmaliandsenegal
AT badjialioune feasibilityofonchocerciasiseliminationwithivermectintreatmentinendemicfociinafricafirstevidencefromstudiesinmaliandsenegal
AT bissanyiriba feasibilityofonchocerciasiseliminationwithivermectintreatmentinendemicfociinafricafirstevidencefromstudiesinmaliandsenegal
AT doumbiakonimba feasibilityofonchocerciasiseliminationwithivermectintreatmentinendemicfociinafricafirstevidencefromstudiesinmaliandsenegal
AT goitasoulaf feasibilityofonchocerciasiseliminationwithivermectintreatmentinendemicfociinafricafirstevidencefromstudiesinmaliandsenegal
AT konatelassana feasibilityofonchocerciasiseliminationwithivermectintreatmentinendemicfociinafricafirstevidencefromstudiesinmaliandsenegal
AT mounkorokalifa feasibilityofonchocerciasiseliminationwithivermectintreatmentinendemicfociinafricafirstevidencefromstudiesinmaliandsenegal
AT sarrmoussad feasibilityofonchocerciasiseliminationwithivermectintreatmentinendemicfociinafricafirstevidencefromstudiesinmaliandsenegal
AT seckamadouf feasibilityofonchocerciasiseliminationwithivermectintreatmentinendemicfociinafricafirstevidencefromstudiesinmaliandsenegal
AT toelaurent feasibilityofonchocerciasiseliminationwithivermectintreatmentinendemicfociinafricafirstevidencefromstudiesinmaliandsenegal
AT toureeseyni feasibilityofonchocerciasiseliminationwithivermectintreatmentinendemicfociinafricafirstevidencefromstudiesinmaliandsenegal
AT remmejanhf feasibilityofonchocerciasiseliminationwithivermectintreatmentinendemicfociinafricafirstevidencefromstudiesinmaliandsenegal